Lorazepam Injection shortage
Current 11 presentations · 4 manufacturers · first FDA posting May 3, 2018 · last update Oct 15, 2026
Manufacturers: Amphastar Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Demand increase for the drug; Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) | Amphastar Pharmaceuticals, Inc. | Current Available |
— | Posted May 3, 2018 Updated Oct 5, 2026 | |
| Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted May 3, 2018 Updated Oct 15, 2026 |
| Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Oct 14, 2026 |
| Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Sep 18, 2026 |
| Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Oct 14, 2026 |
| Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Sep 18, 2026 |
| Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Sep 18, 2026 |
| Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Sep 18, 2026 |
| Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted Sep 5, 2018 Updated Oct 14, 2026 |
| Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted May 3, 2018 Updated Oct 14, 2026 |
| Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: June 2027; Estimated Recovery: December 2027 | Posted May 3, 2018 Updated Oct 8, 2026 |